Drawing for FSL

USPTO serial 87368894

FSL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
VERHOSEK, WILLIAM T
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FSL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsyACTIVE
040Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others; research in the field of manufacturing processesACTIVE
042Research and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; Nutraceutical research and development for others; Cosmeceutical research and development for others; Veterinary medical research and development for others; Research and development in the field of bioinformatics and proteomicsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 9, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 9, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 5, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 25, 2017ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 7, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2017XAECEXAMINER'S AMENDMENT ENTERED
Jun 7, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 7, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Jun 7, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 6, 2017DOCKASSIGNED TO EXAMINER
Mar 17, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance